Haleon plc (LON:HLN - Get Free Report) declared a dividend on Thursday, February 27th, DividendData.Co.Uk reports. Investors of record on Thursday, April 24th will be given a dividend of GBX 4.60 ($0.06) per share on Thursday, June 5th. This represents a dividend yield of 1.18%. The ex-dividend date is Thursday, April 24th. This is a 130.0% increase from Haleon's previous dividend of $2.00. The official announcement can be viewed at this link.
Haleon Stock Up 0.3 %
HLN stock traded up GBX 1.15 ($0.02) during trading on Friday, reaching GBX 377.75 ($5.03). The stock had a trading volume of 48,030,980 shares, compared to its average volume of 26,987,539. The company has a quick ratio of 0.93, a current ratio of 0.84 and a debt-to-equity ratio of 53.36. The company has a market capitalization of £34.09 billion, a price-to-earnings ratio of 31.77, a P/E/G ratio of 1.49 and a beta of 0.19. Haleon has a one year low of GBX 319.84 ($4.26) and a one year high of GBX 417.70 ($5.56). The company's 50 day moving average is GBX 386.42 and its two-hundred day moving average is GBX 379.65.
Haleon (LON:HLN - Get Free Report) last announced its earnings results on Friday, February 28th. The company reported GBX 15.80 ($0.21) earnings per share for the quarter. Haleon had a return on equity of 6.54% and a net margin of 9.66%. Equities research analysts forecast that Haleon will post 19.5033282 EPS for the current year.
Wall Street Analyst Weigh In
Separately, Berenberg Bank raised their target price on Haleon from GBX 456 ($6.07) to GBX 457 ($6.09) and gave the company a "buy" rating in a research report on Friday, February 28th.
Read Our Latest Stock Analysis on Haleon
About Haleon
(
Get Free Report)
Haleon LSE / NYSE: HLN is a world-leading consumer health company, with a clear purpose to deliver better everyday health with humanity. In July 2022, it listed as an independent company on the London and New York Stock Exchanges.
Haleon's portfolio spans five global categories including Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health and Digestive Health and other.
Featured Articles
Before you consider Haleon, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Haleon wasn't on the list.
While Haleon currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
